BNP Paribas Financial Markets’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $278M | Sell |
9,904,502
-6,624,160
| -40% | -$176M | 0.14% | 142 |
|
|
2025
Q4 | $412M | Buy |
16,528,662
+6,867,850
| +71% | +$173M | 0.19% | 93 |
|
|
2025
Q3 | $246M | Sell |
9,660,812
-11,413,258
| -54% | -$282M | 0.13% | 137 |
|
|
2025
Q2 | $511M | Sell |
21,074,070
-4,082,069
| -16% | -$95.2M | 0.29% | 55 |
|
|
2025
Q1 | $637M | Buy |
25,156,139
+6,225,148
| +33% | +$163M | 0.37% | 45 |
|
|
2024
Q4 | $502M | Sell |
18,930,991
-7,221,865
| -28% | -$196M | 0.28% | 58 |
|
|
2024
Q3 | $757M | Buy |
26,152,856
+14,557,032
| +126% | +$425M | 0.51% | 27 |
|
|
2024
Q2 | $324M | Sell |
11,595,824
-1,863,313
| -14% | -$51.3M | 0.26% | 78 |
|
|
2024
Q1 | $373M | Buy |
13,459,137
+3,271,594
| +32% | +$90.8M | 0.33% | 61 |
|
|
2023
Q4 | $293M | Sell |
10,187,543
-607,890
| -6% | -$18.4M | 0.33% | 52 |
|
|
2023
Q3 | $358M | Buy |
10,795,433
+1,046,134
| +11% | +$37M | 0.46% | 26 |
|
|
2023
Q2 | $358M | Buy |
9,749,299
+5,547,555
| +132% | +$216M | 0.45% | 31 |
|
|
2023
Q1 | $171M | Buy |
4,201,744
+660,528
| +19% | +$28.5M | 0.24% | 89 |
|
|
2022
Q4 | $181M | Buy |
3,541,216
+692,252
| +24% | +$33.2M | 0.28% | 72 |
|
|
2022
Q3 | $125M | Sell |
2,848,964
-1,070,705
| -27% | -$52M | 0.2% | 91 |
|
|
2022
Q2 | $206M | Buy |
3,919,669
+1,284,447
| +49% | +$65.5M | 0.32% | 55 |
|
|
2022
Q1 | $136M | Sell |
2,635,222
-1,231,486
| -32% | -$63.9M | 0.18% | 108 |
|
|
2021
Q4 | $228M | Sell |
3,866,708
-503,992
| -12% | -$25M | 0.33% | 52 |
|
|
2021
Q3 | $188M | Sell |
4,370,700
-456,258
| -9% | -$20.2M | 0.27% | 76 |
|
|
2021
Q2 | $189M | Buy |
4,826,958
+1,086,466
| +29% | +$42.3M | 0.25% | 87 |
|
|
2021
Q1 | $136M | Buy |
3,740,492
+1,126,720
| +43% | +$40M | 0.2% | 104 |
|
|
2020
Q4 | $96.2M | Sell |
2,613,772
-2,718,407
| -51% | -$99.7M | 0.18% | 106 |
|
|
2020
Q3 | $186M | Buy |
5,332,179
+344,457
| +7% | +$12.1M | 0.27% | 71 |
|
|
2020
Q2 | $155M | Buy |
4,987,722
+2,591,122
| +108% | +$88M | 0.27% | 71 |
|
|
2020
Q1 | $74.2M | Sell |
2,396,600
-3,371,994
| -58% | -$115M | 0.15% | 131 |
|
|
2019
Q4 | $214M | Sell |
5,768,594
-472,099
| -8% | -$16.8M | 0.39% | 36 |
|
|
2019
Q3 | $213M | Buy |
6,240,693
+1,390,669
| +29% | +$50.6M | 0.38% | 53 |
|
|
2019
Q2 | $199M | Buy |
4,850,024
+551,887
| +13% | +$21.9M | 0.4% | 37 |
|
|
2019
Q1 | $173M | Sell |
4,298,137
-538,973
| -11% | -$21.6M | 0.37% | 45 |
|
|
2018
Q4 | $200M | Sell |
4,837,110
-1,620,307
| -25% | -$67.3M | 0.47% | 30 |
|
|
2018
Q3 | $270M | Sell |
6,457,417
-370,583
| -5% | -$14.3M | 0.4% | 36 |
|
|
2018
Q2 | $235M | Buy |
6,828,000
+1,580,634
| +30% | +$54M | 0.39% | 40 |
|
|
2018
Q1 | $177M | Sell |
5,247,366
-507,107
| -9% | -$17.4M | 0.33% | 51 |
|
|
2017
Q4 | $198M | Sell |
5,754,473
-3,605,975
| -39% | -$123M | 0.35% | 46 |
|
|
2017
Q3 | $317M | Buy |
9,360,448
+854,289
| +10% | +$27.5M | 0.77% | 16 |
|
|
2017
Q2 | $271M | Buy |
8,506,159
+2,412,276
| +40% | +$76.1M | 0.82% | 13 |
|
|
2017
Q1 | $198M | Buy |
6,093,883
+1,211,903
| +25% | +$38.2M | 0.52% | 33 |
|
|
2016
Q4 | $150M | Buy |
4,881,980
+3,247,511
| +199% | +$99.1M | 0.7% | 22 |
|
|
2016
Q3 | $52.5M | Buy |
1,634,469
+277,623
| +20% | +$9.28M | 0.22% | 87 |
|
|
2016
Q2 | $45.3M | Sell |
1,356,846
-1,064,403
| -44% | -$34M | 0.2% | 76 |
|
|
2016
Q1 | $68.1M | Sell |
2,421,249
-3,641,036
| -60% | -$104M | 0.29% | 66 |
|
|
2015
Q4 | $186M | Buy |
6,062,285
+922,919
| +18% | +$29M | 0.45% | 43 |
|
|
2015
Q3 | $153M | Buy |
5,139,366
+3,516,701
| +217% | +$113M | 0.38% | 35 |
|
|
2015
Q2 | $51.6M | Sell |
1,622,665
-4,449,808
| -73% | -$145M | 0.14% | 91 |
|
|
2015
Q1 | $200M | Buy |
6,072,473
+635,659
| +12% | +$20.2M | 0.55% | 31 |
|
|
2014
Q4 | $161M | Sell |
5,436,814
-1,201,568
| -18% | -$34.5M | 0.57% | 29 |
|
|
2014
Q3 | $186M | Buy |
6,638,382
+1,794,512
| +37% | +$50.4M | 0.16% | 91 |
|
|
2014
Q2 | $136M | Sell |
4,843,870
-1,545,657
| -24% | -$44.1M | 0.13% | 92 |
|
|
2014
Q1 | $190M | Buy |
6,389,527
+1,581,991
| +33% | +$47.2M | 0.15% | 87 |
|
|
2013
Q4 | $140M | Sell |
4,807,536
-4,218,994
| -47% | -$123M | 0.1% | 113 |
|
|
2013
Q3 | $246M | Buy |
9,026,530
+4,208,675
| +87% | +$115M | 0.18% | 90 |
|
|
2013
Q2 | $128M | Buy |
+4,817,855
| New | +$133M | 0.09% | 107 |
|
Other funds holding PFE
VCM
VPM
BNP Paribas Financial Markets's PFE Position: Q1 2026 in Review
BNP Paribas Financial Markets reduced its Pfizer (PFE) stake by 40% in Q1 2026, selling an estimated $176M and leaving 9,904,502 shares worth $278M. The position accounts for 0.14% of the portfolio, ranked #142.
BNP Paribas Financial Markets first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $757M in Q3 2024. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- BNP Paribas Financial Markets held 9,904,502 shares of Pfizer worth $278M as of Q1 2026.
- BNP Paribas Financial Markets sold 6,624,160 Pfizer shares in Q1 2026, an estimated $176M.
- Pfizer made up 0.14% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #142 holding.
- BNP Paribas Financial Markets first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Financial Markets's Pfizer position peaked at $757M in Q3 2024.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.